Skip to main content
. 2016 Nov 21;15:53. doi: 10.1186/s40200-016-0276-0

Table 3.

Correlation of study parameters

Correlation between parameters Group 1 Group 2 Group 3
Serum fructosamine (μmol/l) and FBS (mg/dl) r 0.0749 0.6446 0.7644
p 0.6053 <0.0001 <0.0001
Serum fructosamine (μmol/l) and PP2BS (mg/dl) r −0.1174 0.5254 0.8142
p 0.4168 0.0001 <0.0001
Serum glycated albumin (μmol/l) and FBS (mg/dl) r −0.1182 0.5085 0.7675
p 0.9351 0.0002 <0.0001
Serum glycated albumin (μmol/l) and PP2BS (mg/dl) r −0.1785 0.3956 0.8023
p 0.2149 0.0045 <0.0001
Serum glycated β-lipoprotein (μmol/l) and FBS (mg/dl) r 0.0186 0.3702 0.5915
p 0.8979 0.0081 <0.0001
Serum glycated β-lipoprotein (μmol/l) and PP2BS (mg/dl) r −0.1802 0.4013 0.6240
p 0.2105 0.0039 <0.0001
Serum glycated Albumin (μmol/l) and fructosamine (μmol/l) r 0.4896 0.9133 0.9491
p 0.0003 <0.0001 <0.0001
Serum glycated β-lipoprotein (μmol/l) and fructosamine (μmol/l) r 0.3626 0.3073 0.6661
p 0.0097 0.0300 <0.0001
Serum glycated β-lipoprotein (μmol/l) and glycated albumin (μmol/l) r 0.2152 0.1323 0.5625
p 0.1295 0.3549 <0.0001

r = correlation coefficient, p = probability